Skip to main content
. 2018 Jul-Sep;13(3):546–554. doi: 10.4103/ajns.AJNS_266_16

Table 2.

Current and ongoing clinical trials of cilengitide in recurrent and newly diagnosed glioblastoma multiforme

graphic file with name AJNS-13-546-g005.jpg